世界のグランツマン血小板無力症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Glanzmann Thrombasthenia Therapeutic Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4257
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、グランツマン血小板無力症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血小板輸血、組換え活性化第VII因子、抗線溶薬、フィブリンシーラント、トロンビン、デスモプレシン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・グランツマン血小板無力症治療薬の市場動向
・企業の競争状況、市場シェア
・グランツマン血小板無力症治療薬の種類別市場規模と予測2016-2027（血小板輸血、組換え活性化第VII因子、抗線溶薬、フィブリンシーラント、トロンビン、デスモプレシン）
・グランツマン血小板無力症治療薬の用途別市場規模と予測2016-2027（病院、診療所、その他）
・グランツマン血小板無力症治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・グランツマン血小板無力症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・グランツマン血小板無力症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・グランツマン血小板無力症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・グランツマン血小板無力症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novo Nordisk、Alnylam Pharmaceuticals、Shire (Takeda)、Biogen、Bioverativ (Sanofi)、Bayer、CSL Behring、Grifols、Bristol-Myers Squibb、Pfizer）
・結論

Market Analysis and Insights: Global Glanzmann Thrombasthenia Therapeutic Drug Market
The global Glanzmann Thrombasthenia Therapeutic Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glanzmann Thrombasthenia Therapeutic Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Glanzmann Thrombasthenia Therapeutic Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Glanzmann Thrombasthenia Therapeutic Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Glanzmann Thrombasthenia Therapeutic Drug market.

Global Glanzmann Thrombasthenia Therapeutic Drug Scope and Market Size
Glanzmann Thrombasthenia Therapeutic Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glanzmann Thrombasthenia Therapeutic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Platelet Transfusion
Recombinant Activated Factor VII
Antifibrinolytics
Fibrin Sealants
Thrombin
Desmopressin

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novo Nordisk
Alnylam Pharmaceuticals
Shire (Takeda)
Biogen
Bioverativ (Sanofi)
Bayer
CSL Behring
Grifols
Bristol-Myers Squibb
Pfizer

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Platelet Transfusion
1.2.3 Recombinant Activated Factor VII
1.2.4 Antifibrinolytics
1.2.5 Fibrin Sealants
1.2.6 Thrombin
1.2.7 Desmopressin
1.3 Market by Application
1.3.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Perspective (2016-2027)
2.2 Glanzmann Thrombasthenia Therapeutic Drug Growth Trends by Regions
2.2.1 Glanzmann Thrombasthenia Therapeutic Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Glanzmann Thrombasthenia Therapeutic Drug Historic Market Share by Regions (2016-2021)
2.2.3 Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Regions (2022-2027)
2.3 Glanzmann Thrombasthenia Therapeutic Drug Industry Dynamic
2.3.1 Glanzmann Thrombasthenia Therapeutic Drug Market Trends
2.3.2 Glanzmann Thrombasthenia Therapeutic Drug Market Drivers
2.3.3 Glanzmann Thrombasthenia Therapeutic Drug Market Challenges
2.3.4 Glanzmann Thrombasthenia Therapeutic Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Revenue
3.1.1 Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Revenue (2016-2021)
3.1.2 Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Players (2016-2021)
3.2 Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Glanzmann Thrombasthenia Therapeutic Drug Revenue
3.4 Global Glanzmann Thrombasthenia Therapeutic Drug Market Concentration Ratio
3.4.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glanzmann Thrombasthenia Therapeutic Drug Revenue in 2020
3.5 Glanzmann Thrombasthenia Therapeutic Drug Key Players Head office and Area Served
3.6 Key Players Glanzmann Thrombasthenia Therapeutic Drug Product Solution and Service
3.7 Date of Enter into Glanzmann Thrombasthenia Therapeutic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Glanzmann Thrombasthenia Therapeutic Drug Breakdown Data by Type
4.1 Global Glanzmann Thrombasthenia Therapeutic Drug Historic Market Size by Type (2016-2021)
4.2 Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Type (2022-2027)

5 Glanzmann Thrombasthenia Therapeutic Drug Breakdown Data by Application
5.1 Global Glanzmann Thrombasthenia Therapeutic Drug Historic Market Size by Application (2016-2021)
5.2 Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size (2016-2027)
6.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
6.2.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021)
6.2.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027)
6.2.3 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2027)
6.3 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
6.3.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021)
6.3.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027)
6.3.3 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2027)
6.4 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
6.4.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021)
6.4.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size (2016-2027)
7.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
7.2.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021)
7.2.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027)
7.2.3 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2027)
7.3 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
7.3.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021)
7.3.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027)
7.3.3 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2027)
7.4 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
7.4.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021)
7.4.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size (2016-2027)
8.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
8.2.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
8.3.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region
8.4.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size (2016-2027)
9.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
9.2.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021)
9.2.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027)
9.2.3 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2027)
9.3 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
9.3.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021)
9.3.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027)
9.3.3 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2027)
9.4 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
9.4.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021)
9.4.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size (2016-2027)
10.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type
10.2.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application
10.3.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country
10.4.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.1.4 Novo Nordisk Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.1.5 Novo Nordisk Recent Development
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Details
11.2.2 Alnylam Pharmaceuticals Business Overview
11.2.3 Alnylam Pharmaceuticals Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.2.4 Alnylam Pharmaceuticals Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.2.5 Alnylam Pharmaceuticals Recent Development
11.3 Shire (Takeda)
11.3.1 Shire (Takeda) Company Details
11.3.2 Shire (Takeda) Business Overview
11.3.3 Shire (Takeda) Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.3.4 Shire (Takeda) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.3.5 Shire (Takeda) Recent Development
11.4 Biogen
11.4.1 Biogen Company Details
11.4.2 Biogen Business Overview
11.4.3 Biogen Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.4.4 Biogen Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.4.5 Biogen Recent Development
11.5 Bioverativ (Sanofi)
11.5.1 Bioverativ (Sanofi) Company Details
11.5.2 Bioverativ (Sanofi) Business Overview
11.5.3 Bioverativ (Sanofi) Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.5.4 Bioverativ (Sanofi) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.5.5 Bioverativ (Sanofi) Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.6.4 Bayer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 CSL Behring
11.7.1 CSL Behring Company Details
11.7.2 CSL Behring Business Overview
11.7.3 CSL Behring Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.7.4 CSL Behring Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.7.5 CSL Behring Recent Development
11.8 Grifols
11.8.1 Grifols Company Details
11.8.2 Grifols Business Overview
11.8.3 Grifols Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.8.4 Grifols Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.8.5 Grifols Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.9.4 Bristol-Myers Squibb Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.10.4 Pfizer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
11.10.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Platelet Transfusion
Table 3. Key Players of Recombinant Activated Factor VII
Table 4. Key Players of Antifibrinolytics
Table 5. Key Players of Fibrin Sealants
Table 6. Key Players of Thrombin
Table 7. Key Players of Desmopressin
Table 8. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Regions (2016-2021)
Table 12. Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Regions (2022-2027)
Table 14. Glanzmann Thrombasthenia Therapeutic Drug Market Trends
Table 15. Glanzmann Thrombasthenia Therapeutic Drug Market Drivers
Table 16. Glanzmann Thrombasthenia Therapeutic Drug Market Challenges
Table 17. Glanzmann Thrombasthenia Therapeutic Drug Market Restraints
Table 18. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Players (2016-2021)
Table 20. Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glanzmann Thrombasthenia Therapeutic Drug as of 2020)
Table 21. Ranking of Global Top Glanzmann Thrombasthenia Therapeutic Drug Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Glanzmann Thrombasthenia Therapeutic Drug Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Glanzmann Thrombasthenia Therapeutic Drug Product Solution and Service
Table 25. Date of Enter into Glanzmann Thrombasthenia Therapeutic Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Type (2016-2021)
Table 29. Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Application (2016-2021)
Table 33. Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 65. Novo Nordisk Company Details
Table 66. Novo Nordisk Business Overview
Table 67. Novo Nordisk Glanzmann Thrombasthenia Therapeutic Drug Product
Table 68. Novo Nordisk Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 69. Novo Nordisk Recent Development
Table 70. Alnylam Pharmaceuticals Company Details
Table 71. Alnylam Pharmaceuticals Business Overview
Table 72. Alnylam Pharmaceuticals Glanzmann Thrombasthenia Therapeutic Drug Product
Table 73. Alnylam Pharmaceuticals Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 74. Alnylam Pharmaceuticals Recent Development
Table 75. Shire (Takeda) Company Details
Table 76. Shire (Takeda) Business Overview
Table 77. Shire (Takeda) Glanzmann Thrombasthenia Therapeutic Drug Product
Table 78. Shire (Takeda) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 79. Shire (Takeda) Recent Development
Table 80. Biogen Company Details
Table 81. Biogen Business Overview
Table 82. Biogen Glanzmann Thrombasthenia Therapeutic Drug Product
Table 83. Biogen Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 84. Biogen Recent Development
Table 85. Bioverativ (Sanofi) Company Details
Table 86. Bioverativ (Sanofi) Business Overview
Table 87. Bioverativ (Sanofi) Glanzmann Thrombasthenia Therapeutic Drug Product
Table 88. Bioverativ (Sanofi) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 89. Bioverativ (Sanofi) Recent Development
Table 90. Bayer Company Details
Table 91. Bayer Business Overview
Table 92. Bayer Glanzmann Thrombasthenia Therapeutic Drug Product
Table 93. Bayer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 94. Bayer Recent Development
Table 95. CSL Behring Company Details
Table 96. CSL Behring Business Overview
Table 97. CSL Behring Glanzmann Thrombasthenia Therapeutic Drug Product
Table 98. CSL Behring Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 99. CSL Behring Recent Development
Table 100. Grifols Company Details
Table 101. Grifols Business Overview
Table 102. Grifols Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 103. Grifols Recent Development
Table 104. Bristol-Myers Squibb Company Details
Table 105. Bristol-Myers Squibb Business Overview
Table 106. Bristol-Myers Squibb Glanzmann Thrombasthenia Therapeutic Drug Product
Table 107. Bristol-Myers Squibb Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 108. Bristol-Myers Squibb Recent Development
Table 109. Pfizer Company Details
Table 110. Pfizer Business Overview
Table 111. Pfizer Glanzmann Thrombasthenia Therapeutic Drug Product
Table 112. Pfizer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 113. Pfizer Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type: 2020 VS 2027
Figure 2. Platelet Transfusion Features
Figure 3. Recombinant Activated Factor VII Features
Figure 4. Antifibrinolytics Features
Figure 5. Fibrin Sealants Features
Figure 6. Thrombin Features
Figure 7. Desmopressin Features
Figure 8. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Glanzmann Thrombasthenia Therapeutic Drug Report Years Considered
Figure 13. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Regions: 2020 VS 2027
Figure 16. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Regions (2022-2027)
Figure 17. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Players in 2020
Figure 18. Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glanzmann Thrombasthenia Therapeutic Drug as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Glanzmann Thrombasthenia Therapeutic Drug Revenue in 2020
Figure 20. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Type (2016-2021)
Figure 21. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Type (2022-2027)
Figure 22. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2016-2027)
Figure 24. North America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2016-2027)
Figure 25. North America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2016-2027)
Figure 26. United States Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2016-2027)
Figure 30. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2016-2027)
Figure 31. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2016-2027)
Figure 32. Germany Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Share by Region (2016-2027)
Figure 42. China Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2016-2027)
Figure 50. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2016-2027)
Figure 51. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2016-2027)
Figure 52. Mexico Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2016-2027)
Figure 58. Turkey Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Novo Nordisk Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
Figure 62. Alnylam Pharmaceuticals Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
Figure 63. Shire (Takeda) Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
Figure 64. Biogen Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
Figure 65. Bioverativ (Sanofi) Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
Figure 67. CSL Behring Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
Figure 68. Grifols Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の副鼻腔治療薬市場規模・現状・予測（2021年-2027年）

Global Sinus Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4863 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、副鼻腔治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、局所、注射）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の抗凝固治療薬モニタリングアッセイキット市場規模・現状・予測（2021年-2027年）

Global Anticoagulant Therapeutic Drug Monitoring Assay Kit Market Size, Status and Forecast 2021-2027
QFJ1-3824 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、抗凝固治療薬モニタリングアッセイキットの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（蛍光偏光免疫測定法、均一酵素免疫測定法、酵素結合免疫吸着測定法）、用途別市場規模（病院、診療所、その他）、主要地域...

世界のB型肝炎用治療薬市場規模・現状・予測（2021年-2027年）

Global Hepatitis B Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-5777 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、B型肝炎用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他）、用途別市場規模（病院薬局、小売薬局＆ドラッグストア、その他）...

世界の核医学治療薬市場規模・現状・予測（2021年-2027年）

Global Nuclear Drug for Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5899 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、核医学治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ラジウム-223、ルテチウム-177、ヨウ素-131、その他）、用途別市場規模（甲状腺、骨転移、リンパ腫、その他）、主要地域別市場規模（北米...

世界の核医療治療薬市場規模・現状・予測（2021年-2027年）

Global Therapeutic Nuclear Drug Market Size, Status and Forecast 2021-2027
QFJ1-6035 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、核医療治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ラジウム-223、ルテチウム-177、ヨウ素-131、その他）、用途別市場規模（甲状腺、骨転移、リンパ腫、その他）、主要地域別市場規模（北米...

世界の糖尿病性神経障害治療薬市場規模・現状・予測（2021年-2027年）

Global Diabetic Neurological Disorder Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4124 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、糖尿病性神経障害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、ピル、その他）、用途別市場規模（対称性神経障害、焦点＆多巣性神経障害）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の不安障害＆うつ病治療薬市場規模・現状・予測（2021年-2027年）

Global Anxiety Disorders And Depression Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-5593 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、不安障害＆うつ病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（SSRI、SNRI、TeCA、TCA、MAOI、非定型抗精神病薬、ベンゾジアゼピン、抗けいれん薬、ベータ遮断薬、その他）、用途別市...

世界の外分泌膵機能不全治療市場規模・現状・予測（2021年-2027年）

Global Exocrine Pancreatic Insufficiency Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5732 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、外分泌膵機能不全治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（膵酵素補充療法、栄養療法）、用途別市場規模（病院薬局、小売薬局＆ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のリンパ芽球性リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Lymphoblastic Lymphoma Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5837 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、リンパ芽球性リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、幹細胞移植、標的療法、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のマゴットセラピー市場規模・現状・予測（2021年-2027年）

Global Maggot Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-4454 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、マゴットセラピーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬品、薬用包帯、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の抗凝固治療薬モニタリングアッセイキット市場規模・現状・予測（2021年-2027年） Anticoagulant therapeutic drugs prevent or reduce blood coagulation and delay clotting time which can block arteries, veins or the valves of the heart. Market Analysis and Insights: Global Anticoagulant Therapeutic Drug Monitoring Assay Kit Market The global Anticoagulant Therapeutic Drug Monitoring…
世界の副鼻腔治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sinus Therapeutic Drug Market The global Sinus Therapeutic Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…
世界のB型肝炎用治療薬市場規模・現状・予測（2021年-2027年） Treatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medications — including entecavir (Baraclude), tenofovir (Viread), lamivudine (Epivir), adefovir (Hepsera) and telbivudine (Tyzeka) — can help fight the virus and slow its ability to damage your liver. Market Ana…
世界の核医療治療薬市場規模・現状・予測（2021年-2027年） Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capab…
世界の核医学治療薬市場規模・現状・予測（2021年-2027年） Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capab…